Additional file 3 of A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Authors :: Devos, Timothy
Geukens, Tatjana
Schauvlieghe, Alexander
Ariën, Kevin K.
Barbezange, Cyril
Cleeren, Myriam
Compernolle, Veerle
Dauby, Nicolas
Desmecht, Daniël
Grimaldi, David
Lambrecht, Bart N.
Luyten, Anne
Maes, Piet
Moutschen, Michel
Romano, Marta
Seyler, Lucie
Nevessignsky, Michel Toungouz
Vandenberghe, Katleen
Griensven, Johan Van
Verbeke, Geert
Vlieghe, Erika
Yombi, Jean Cyr
Liesenborghs, Laurens
Verhamme, Peter
Meyfroidt, Geert
Publication Year :: 2020
Publisher :: figshare, 2020.
Abstract: Additional file 3.

Full Text Access

Tools